Status:
TERMINATED
Inflammatory Mediators and microRNA Analysis in Premenstrual Asthma
Lead Sponsor:
Ohio State University
Conditions:
Asthma
Eligibility:
FEMALE
18+ years
Brief Summary
A small number of women with asthma have an increase in asthma symptoms during the premenstrual or menstrual period. This study is being done to investigate the possible causes of this premenstrual in...
Detailed Description
It is well established that women suffer more asthma symptoms and worse health-related quality of life than men with the same level of asthma severity. The etiology for these sex-related differences i...
Eligibility Criteria
Inclusion
- Diagnosis of asthma
Exclusion
- Are pregnant
- Take hormonal medication
- Have an illness with fever (\> 38.0 ˚ C or 100.4 ˚ F) within 24 hours of Visit 1 or between Visits 1 and 2
- Are participating in another interventional research trial
- Have other major chronic illnesses that would interfere with participation
- Are taking the following medications: leukotriene receptor antagonists, oral steroids, anticoagulants, or insulin
- Are unable to provide consent
Key Trial Info
Start Date :
February 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT00837395
Start Date
February 1 2009
End Date
December 1 2019
Last Update
April 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ohio State University
Columbus, Ohio, United States, 43210